Ole Thastrup

Founder at 2CUREX AB

73 year

Health Technology

Consumer Non-Durables

Miscellaneous

Profile

Ole Thastrup is the founder of 2cureX ApS, where he holds the title of Director & Chief Scientific Officer since 2006.
He is also the founder of 2cureX AB, where he holds the title of Vice Chairman & Chief Executive Officer since 2024.
Dr. Thastrup is also the founder of Noapab Holdings A..
Dr. Thastrup's current job(s) include being the Chief Executive Officer & Director at Ot311 ApS, a Member at Novo Nordisk Fonden, and the Head-Drug Design Department & Professor at the University of Copenhagen.
Dr. Thastrup's former job(s) include being a Principal at ZymoGenetics, Inc. and Novo Nordisk A, as well as being the Head-Biosector at Carlsberg A from 2002 to 2006.

Latest news about Ole Thastrup

11/07/25	Improved communication from 2cureX AB	AQ
01/07/25	2cureX AB is in the process of securing a strategic collaboration with PreComb Therapeutics AG.	AQ
30/05/25	NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (publ).	AQ
15/05/25	2cureX AB (2CUREX) Launches “Operation Twin Code” with New Investors, Leadership Transition, and Global Roadmap	AQ
16/12/24	2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of commercial expansion of breakthrough precision oncology products	AQ

Ole Thastrup active positions

Companies	Position	Start
2CUREX AB	Founder	31/12/2005
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Founder	31/12/2005
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Ot311 ApS	Chief Executive Officer	-
Novo Nordisk Fonden Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Corporate Officer/Principal	-

All active positions of Ole Thastrup

Former positions of Ole Thastrup

Companies	Position	End
CARLSBERG A/S	Corporate Officer/Principal	31/12/2005
Noapab Holdings A/S Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products	Chief Tech/Sci/R&D Officer	-
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs	Corporate Officer/Principal	-
NOVO NORDISK A/S	Corporate Officer/Principal	-

See the detail of Ole Thastrup's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ole Thastrup's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs	Health Technology
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Carlsberg A/S Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks	Consumer Non-Durables
Novo Nordisk Fonden Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Miscellaneous
Noapab Holdings A/S Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products	Commercial Services
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Health Technology
2cureX AB 2cureX AB Develops and supplies in vitro diagnostic (IVD) devices
Ot311 ApS

See company connections

Stock Market
Insiders
Ole Thastrup